Cancer Health Treatment Update Reconsidering End-of-Life Treatment for People With Advanced Cancer Patients treated at oncology practices that frequently offer systemic therapy during the last two weeks of life did not have a survival advantage over those treated at practices that did so less often. Jemperli Immunotherapy Continues to Show 100% Response Rate for Rectal Cancer All rectal cancer patients with a specific genetic mutation had a complete response to the checkpoint inhibitor, and some were still in remission four years later. FDA Approves Blood Test for Colon Cancer Guardant Health’s Shield blood test may help improve screening rates—but it doesn’t replace colonoscopies. Cancer Health Summer 2024 Check out our latest print edition! News From ASCO 2024 See all our reports from the world's biggest cancer conference. Advertisement BRCA1/2: Why Men Should Be Screened for the “Breast Cancer Gene” Men who carry mutations in the BRCA1 and BRCA2 genes can see increased risk of several cancers. New guidelines help educate patients. News About COVID-19 See all our coverage of COVID-19, including how it affects people living with cancer. For more news about SARS-CoV-2, visit our sister site, COVIDHealth.com. Newsfeed FDA Approves Blood Test for Colon Cancer FDA Ban on Formaldehyde in Hair Products Delayed … Again BRCA1/2: Why Men Should Be Screened for the “Breast Cancer Gene” Pesticides May Be as Bad as Smoking for Increased Risk in Certain Cancers Blog: National Cancer Institute FDA Approves HPV Tests That Allow for Self-Collection in a Health Care Setting Treating the Whole Person: How Cancer Centers Are Addressing Social Needs Lorbrena Is Effective as Initial Treatment of ALK-Positive Non-Small-Cell Lung Cancer Trial Establishes Preferred Treatment for Some People With Esophageal Cancer Newsfeed FDA Approves Blood Test for Colon Cancer FDA Ban on Formaldehyde in Hair Products Delayed … Again BRCA1/2: Why Men Should Be Screened for the “Breast Cancer Gene” Pesticides May Be as Bad as Smoking for Increased Risk in Certain Cancers Blog: National Cancer Institute FDA Approves HPV Tests That Allow for Self-Collection in a Health Care Setting Treating the Whole Person: How Cancer Centers Are Addressing Social Needs Lorbrena Is Effective as Initial Treatment of ALK-Positive Non-Small-Cell Lung Cancer Trial Establishes Preferred Treatment for Some People With Esophageal Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: